Sophia Genetics SA | Micro-cap | Healthcare
$3.41
-0.58%
| Sophia Genetics SA Stock Comparison:
Sophia Genetics SA vs Veeva SystemsSophia Genetics SA vs Ge HealthcareSophia Genetics SA vs PerformantSophia Genetics SA vs LifeMDSophia Genetics SA vs American WellSophia Genetics SA vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 18.3M
Gross Profit 12.3M 66.97%
Operating Income -18.5M -100.92%
Net Income -22.4M -122.33%
EPS (Diluted) $-0.33

Balance Sheet Metrics

Total Assets 146.7M
Total Liabilities 61.1M
Shareholders Equity 85.6M
Debt to Equity 0.71

Cash Flow Metrics

Operating Cash Flow -11.2M
Free Cash Flow -12.2M

Revenue & Profitability Trend

Sophia Genetics SA Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i65.2M62.4M47.6M40.4M28.4M
Cost of Goods Sold i21.2M19.5M16.3M15.2M10.7M
Gross Profit i43.9M42.9M31.3M25.2M17.7M
Gross Margin % i67.4%68.8%65.7%62.4%62.3%
Operating Expenses
Research & Development i34.4M37.0M35.4M26.6M18.6M
Selling, General & Administrative i76.3M81.7M84.1M70.2M36.4M
Other Operating Expenses i-183.0K-954.0K-377.0K-108.0K93.0K
Total Operating Expenses i110.5M117.7M119.1M96.7M55.1M
Operating Income i-66.6M-74.8M-87.8M-71.5M-37.4M
Operating Margin % i-102.1%-120.0%-184.7%-176.7%-131.6%
Non-Operating Items
Interest Income i3.4M4.5M1.3M20.0K96.0K
Interest Expense i1.9M588.0K639.0K658.0K840.0K
Other Non-Operating Income3.8M-7.6M-447.0K-1.4M-3.1M
Pre-tax Income i-61.3M-78.5M-87.6M-73.5M-41.2M
Income Tax i1.2M486.0K-136.0K168.0K-1.9M
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-62.5M-79.0M-87.4M-73.7M-39.3M
Net Margin % i-95.9%-126.6%-183.9%-182.1%-138.5%
Key Metrics
EBITDA i-54.6M-61.9M-80.9M-67.9M-34.9M
EPS (Basic) i$-0.95$-1.22$-1.36$-1.33$-0.82
EPS (Diluted) i$-0.95$-1.22$-1.36$-1.33$-0.82
Basic Shares Outstanding i6578210564750886640992135529986348019413
Diluted Shares Outstanding i6578210564750886640992135529986348019413

Income Statement Trend

Sophia Genetics SA Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i80.2M123.3M161.3M193.0M74.6M
Short-term Investments i-017.3M72.4M22.7M
Accounts Receivable i7.1M10.3M6.1M7.1M8.9M
Inventory i5.9M6.5M5.2M5.7M3.4M
Other Current Assets835.0K345.0K731.0K625.0K9.0K
Total Current Assets i99.4M148.0M196.3M282.9M109.7M
Non-Current Assets
Property, Plant & Equipment i00003.8M
Goodwill i37.3M36.2M28.2M24.0M21.9M
Intangible Assets i20.7M18.2M11.8M7.4M4.7M
Long-term Investments-----
Other Non-Current Assets6.0M6.5M5.3M8.0M4.3M
Total Non-Current Assets i55.9M58.1M47.6M37.3M22.4M
Total Assets i155.3M206.2M243.8M320.2M132.1M
Liabilities
Current Liabilities
Accounts Payable i1.9M2.3M2.2M2.3M1.3M
Short-term Debt i2.2M2.9M2.7M1.8M3.9M
Current Portion of Long-term Debt-----
Other Current Liabilities444.0K--12.0K48.0K
Total Current Liabilities i26.8M35.6M26.8M28.6M21.6M
Non-Current Liabilities
Long-term Debt i27.8M15.7M14.1M11.2M3.3M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities337.0K334.0K170.0K471.0K-
Total Non-Current Liabilities i32.0M19.1M16.9M16.2M10.0M
Total Liabilities i58.8M54.7M43.7M44.8M31.6M
Equity
Common Stock i4.2M4.0M3.5M3.3M2.5M
Retained Earnings i-440.3M-377.8M-298.8M-211.4M-137.7M
Treasury Stock i702.0K646.0K117.0K0-
Other Equity-----
Total Shareholders Equity i96.5M151.4M200.1M275.4M100.5M
Key Metrics
Total Debt i30.0M18.6M16.7M13.1M7.2M
Working Capital i72.6M112.4M169.4M254.3M88.1M

Balance Sheet Composition

Sophia Genetics SA Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-61.3M-78.5M-87.6M-73.5M-41.2M
Depreciation & Amortization i8.6M8.3M5.6M3.6M2.4M
Stock-Based Compensation i16.5M15.2M13.6M8.5M1.4M
Working Capital Changes i-1.4M-503.0K-296.0K8.4M3.8M
Operating Cash Flow i-43.5M-54.3M-70.7M-54.3M-33.3M
Investing Activities
Capital Expenditures i-244.0K-1.5M-4.1M-2.7M-450.0K
Acquisitions i-----
Investment Purchases i00-26.2M-72.1M-21.1M
Investment Sales i017.5M78.5M21.9M0
Investing Cash Flow i-244.0K16.1M48.3M-52.9M-21.6M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i13.9M-0015.8M
Debt Repayment i-2.8M-3.0M-2.3M-4.1M-17.5M
Financing Cash Flow i11.2M-3.0M-2.3M233.2M106.0M
Free Cash Flow i-51.0M-57.8M-80.5M-64.6M-34.9M
Net Change in Cash i-32.6M-41.3M-24.7M126.0M51.1M

Cash Flow Trend

Sophia Genetics SA Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -3.61
Forward P/E -4.27
Price to Book 3.05
Price to Sales 3.36
PEG Ratio -0.08

Profitability Ratios

Profit Margin -105.32%
Operating Margin -100.92%
Return on Equity -74.09%
Return on Assets -23.46%

Financial Health

Current Ratio 3.39
Debt to Equity 83.21
Beta 1.00

Per Share Data

EPS (TTM) $-1.10
Book Value per Share $1.14
Revenue per Share $1.04

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
soph226.4M-3.613.05-74.09%-105.32%83.21
Veeva Systems 44.1B55.526.6613.70%27.29%1.29
Ge Healthcare 39.5B15.113.4725.80%11.22%107.67
Performant 218.4M-58.697.33-1.12%-0.64%11.04
LifeMD 199.6M-11.64716.45543.53%-2.41%5,767.28
American Well 122.2M-0.490.39-37.62%-46.16%2.17

Financial data is updated regularly. All figures are in the company's reporting currency.